Approval letter, March 15th of 2016
To whom it may concern, we've finally finished your request and run tests, and have officially labeled the pills as safe to use, even though it seems the first batch was already released earlier.
Approval has been given for experiment A-589, also called Quickhelper pills. The second batch of pills is ready to be released, and the trial phase shall be started. There's no seen issues in the release of our trial product, tested using a variety of ethic and professional methods.
Approved medication to be used for trauma regulation, stress response dampening and recovery aid. Can be sold to customers without any prescribed documents needed, but use must be monitored by at the very least writing instroductions on the bottle. Mandated warning labels and controlled sales. Breaking the rules may result in product being taken down from sale. Wrong use may lead to death, and portions should be sold in the right size of 10 milligrams. Introductions must include the possible side effects. They are listed below with all the reports on the subjects.
Subjects had full cognitive awareness, yet the pills kept it partly preserved. Some of the subjects experienced minor motor delays. Their physical responses were also slower than usual. If more stress was put over the subjects, their motor control was nearly lost, which wasn't a problem since your pills eliminated the stress. Once the subjects started an action, they had no way they could stop it. This symptom worried many people in our laboratory, but when we looked into it further, the statistics of health, physical and mental, and brain waves seemed to calm down and recover faster, reducing stress by 60%. In casual use, the possible symptoms that appear as side effects should not make normal life impossible, or cause danger to themself or others, which permits the possiblility of patient development and faster healing.
We have tips for your product sales. We recommend limited release due to the possible side effects. Monitoring who buys them or setting limitations or restrictions can be responsible. Making statistics and letting the customers leave reviews is a good way to get to know what you could change or update about them. These are judt recommendations, and don't have to be acted on, though preferable. Though it's not essential, we would also like to continue further data collection.
Best regards the staff of FHON, the medical researxh center For Health of Newland.